any reason why the success of atz4 can't be repeated, investment metrics well and truly stack up if they can keep doing that? ... what are collective thoughts, i presume atz4 has partially derisked the field ... CEO has no stock but 15m ctro, so I would like to believe dilution would be minimal from here (no pun intended) ... any chance that the tortise prospect can pay off in a signif way, or is it minimal at best? ... oilman you alluded to resource quantum having the potential to improve markedly (I think with 3D seismic, as opposed to 2D, maybe I was dreaming), is that approx a 50/50 chance, ie increase or decrease? ... it is interesting that it is producing from zones which were not primary targets, maybe there is life in this dog yet?
- Forums
- ASX - By Stock
- ETR
- re news one day
re news one day, page-20
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ETR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.88M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ETR (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online